Performance evaluation of the βLACTA™ Test for rapid detection of ceftazidime resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

被引：1

作者：

Ract, Pauline ^{[1
,2
]}

Dahoumane, Redouane ^{[4
]}

Gallah, Salah ^{[3
]}

Morand, Philippe ^{[5
]}

Podglajen, Isabelle ^{[1
,2
]}

Compain, Fabrics ^{[1
,2
,6
,7
]}

机构：

[1] Hop Europeen Georges Pompidou, AP HP, Serv Microbiol, Paris, France

[2] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France

[3] St Antoine Hosp, Dept Microbiol, Paris, France

[4] Hop Univ Est Parisiens, AP HP, Dept Bacteriol, Paris, France

[5] Cochin Hosp, Dept Microbiol, Paris, France

[6] Ctr Rech Cordeliers, INSERM UMRS 1138, Paris, France

[7] UPMC Univ Paris 06, Ctr Rech Cordeliers, Sorbonne Univ, Paris, France

来源：

JOURNAL OF MICROBIOLOGICAL METHODS | 2019年 / 158卷

关键词：

beta LACTA test; Ceftazidime; Cystic fibrosis; Pseudomonas; Rapid test; BETA-LACTA TEST; MECHANISMS; EMERGENCE;

D O I：

10.1016/j.mimet.2019.01.019

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The chromogenic beta LACTA (TM) test was evaluated to detect ceftazidime resistance in P. aeruginosa isolates from patients with cystic fibrosis. Best results were obtained after one hour of incubation with low sensitivity (64.1%), high specificity (98.3%), and negative and positive predictive values of 80.3% and 96.2%, respectively.

引用

页码：21 / 24

页数：4

共 50 条

[1] Evaluation of the βLACTA Test, a Novel Commercial Chromogenic Test for Rapid Detection of Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates
Laurent, Terry
Huang, Te-Din
Bogaerts, Pierre
Glupczynski, Youri
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (06) : 1951 - 1954
[2] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
Manduru, M
Mihm, LB
White, RL
Friedrich, LV
Flume, PA
Bosso, JA
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
[3] Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
Jalal, S
Ciofu, O
Hoiby, N
Gotoh, N
Wretlind, B
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 710 - 712
[4] Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
Islam, S.
Oh, H.
Jalal, S.
Karpati, F.
Ciofu, O.
Hoiby, N.
Wretlind, B.
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (01) : 60 - 66
[5] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
Christenson, JC
Korgenski, EK
Daly, JA
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 899 - 901
[6] Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients
Saiman, L
Burns, JL
Larone, D
Chen, YH
Garber, E
Whittier, S
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) : 492 - 494
[7] EVALUATION OF BIOFILM PRODUCTION BY PSEUDOMONAS AERUGINOSA ISOLATES RECOVERED FROM CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS PATIENTS
Perez, L. R. R.
Costa, M. C. N.
Freitas, A. L. P.
Barth, A. L.
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2011, 42 (02) : 476 - 479
[8] MECHANISM OF AMIKACIN RESISTANCE IN PSEUDOMONAS-AERUGINOSA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS
HURLEY, JC
MILLER, GH
SMITH, AL
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (04) : 331 - 336
[9] Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients
Lopez-Causape, Carla
Maruri-Aransolo, Ainhize
Gomis-Font, Maria A.
Penev, Ivan
Castillo, Maria Garcia
Mulet, Xavier
Caballero, Juan de Dios
del Campo, Rosa
Canton, Rafael
Oliver, Antonio
CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 538.e7 - 538.e13
[10] Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Vettoretti, Lucie
Plesiat, Patrick
Muller, Cedric
El Garch, Farid
Phan, Gilles
Attree, Inna
Ducruix, Arnaud
Llanes, Catherine
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1987 - 1997

← 1 2 3 4 5 →